本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

174.96
-1.5300-0.87%
盘后174.960.00000.00%17:23 EDT
成交量:38.73万
成交额:6,787.28万
市值:105.95亿
市盈率:-27.80
高:177.18
开:176.42
低:173.78
收:176.49
数据加载中...
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities